Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System
Sponsor: Memorial Sloan Kettering Cancer Center
Listed as NCT02565017, this observational or N/A phase trial focuses on Breast Cancer and Colorectal Cancer and remains completed. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 12 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jul 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2019 — Jul 2020 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Sep 2018 — Sep 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2017 — Sep 2017 [monthly]
Recruiting NA
-
Apr 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .